158 related articles for article (PubMed ID: 17188903)
1. In vivo mapping of functional connectivity in neurotransmitter systems using pharmacological MRI.
Schwarz AJ; Gozzi A; Reese T; Bifone A
Neuroimage; 2007 Feb; 34(4):1627-36. PubMed ID: 17188903
[TBL] [Abstract][Full Text] [Related]
2. Functional connectivity in the rat brain: a complex network approach.
Bifone A; Gozzi A; Schwarz AJ
Magn Reson Imaging; 2010 Oct; 28(8):1200-9. PubMed ID: 20813478
[TBL] [Abstract][Full Text] [Related]
3. Pharmacological modulation of functional connectivity: the correlation structure underlying the phMRI response to d-amphetamine modified by selective dopamine D3 receptor antagonist SB277011A.
Schwarz AJ; Gozzi A; Reese T; Heidbreder CA; Bifone A
Magn Reson Imaging; 2007 Jul; 25(6):811-20. PubMed ID: 17442525
[TBL] [Abstract][Full Text] [Related]
4. Drug-anaesthetic interaction in phMRI: the case of the psychotomimetic agent phencyclidine.
Gozzi A; Schwarz A; Crestan V; Bifone A
Magn Reson Imaging; 2008 Sep; 26(7):999-1006. PubMed ID: 18486387
[TBL] [Abstract][Full Text] [Related]
5. A multimodality investigation of cerebral hemodynamics and autoregulation in pharmacological MRI.
Gozzi A; Ceolin L; Schwarz A; Reese T; Bertani S; Crestan V; Bifone A
Magn Reson Imaging; 2007 Jul; 25(6):826-33. PubMed ID: 17451905
[TBL] [Abstract][Full Text] [Related]
6. Functional magnetic resonance mapping of intracerebroventricular infusion of a neuroactive peptide in the anaesthetised rat.
Gozzi A; Schwarz AJ; Reese T; Crestan V; Bertani S; Turrini G; Corsi M; Bifone A
J Neurosci Methods; 2005 Mar; 142(1):115-24. PubMed ID: 15652624
[TBL] [Abstract][Full Text] [Related]
7. Differential responses in CBF and CBV to cocaine as measured by fMRI: implications for pharmacological MRI signals derived oxygen metabolism assessment.
Luo F; Schmidt KF; Fox GB; Ferris CF
J Psychiatr Res; 2009 Aug; 43(12):1018-24. PubMed ID: 19135215
[TBL] [Abstract][Full Text] [Related]
8. Pharmacological MRI in awake rats predicts selective binding of alpha4beta2 nicotinic receptors.
Chin CL; Pauly JR; Surber BW; Skoubis PD; McGaraughty S; Hradil VP; Luo Y; Cox BF; Fox GB
Synapse; 2008 Mar; 62(3):159-68. PubMed ID: 18081183
[TBL] [Abstract][Full Text] [Related]
9. Concurrent pharmacological MRI and in situ microdialysis of cocaine reveal a complex relationship between the central hemodynamic response and local dopamine concentration.
Schwarz AJ; Zocchi A; Reese T; Gozzi A; Garzotti M; Varnier G; Curcuruto O; Sartori I; Girlanda E; Biscaro B; Crestan V; Bertani S; Heidbreder C; Bifone A
Neuroimage; 2004 Sep; 23(1):296-304. PubMed ID: 15325377
[TBL] [Abstract][Full Text] [Related]
10. Test-retest reliability of the BOLD pharmacological MRI response to ketamine in healthy volunteers.
De Simoni S; Schwarz AJ; O'Daly OG; Marquand AF; Brittain C; Gonzales C; Stephenson S; Williams SC; Mehta MA
Neuroimage; 2013 Jan; 64():75-90. PubMed ID: 23009959
[TBL] [Abstract][Full Text] [Related]
11. A stereotaxic MRI template set for the rat brain with tissue class distribution maps and co-registered anatomical atlas: application to pharmacological MRI.
Schwarz AJ; Danckaert A; Reese T; Gozzi A; Paxinos G; Watson C; Merlo-Pich EV; Bifone A
Neuroimage; 2006 Aug; 32(2):538-50. PubMed ID: 16784876
[TBL] [Abstract][Full Text] [Related]
12. Community structure and modularity in networks of correlated brain activity.
Schwarz AJ; Gozzi A; Bifone A
Magn Reson Imaging; 2008 Sep; 26(7):914-20. PubMed ID: 18479871
[TBL] [Abstract][Full Text] [Related]
13. Study-level wavelet cluster analysis and data-driven signal models in pharmacological MRI.
Schwarz AJ; Whitcher B; Gozzi A; Reese T; Bifone A
J Neurosci Methods; 2007 Jan; 159(2):346-60. PubMed ID: 16935348
[TBL] [Abstract][Full Text] [Related]
14. Functional connectivity in the pharmacologically activated brain: resolving networks of correlated responses to d-amphetamine.
Schwarz AJ; Gozzi A; Reese T; Bifone A
Magn Reson Med; 2007 Apr; 57(4):704-13. PubMed ID: 17390353
[TBL] [Abstract][Full Text] [Related]
15. A robust experimental protocol for pharmacological fMRI in rats and mice.
Ferrari L; Turrini G; Crestan V; Bertani S; Cristofori P; Bifone A; Gozzi A
J Neurosci Methods; 2012 Feb; 204(1):9-18. PubMed ID: 22068031
[TBL] [Abstract][Full Text] [Related]
16. Mapping the hemodynamic response in human subjects to a dopaminergic challenge with dextroamphetamine using ASL-based pharmacological MRI.
Schouw ML; Kaag AM; Caan MW; Heijtel DF; Majoie CB; Nederveen AJ; Booij J; Reneman L
Neuroimage; 2013 May; 72():1-9. PubMed ID: 23296186
[TBL] [Abstract][Full Text] [Related]
17. BOLD functional MRI in disease and pharmacological studies: room for improvement?
Iannetti GD; Wise RG
Magn Reson Imaging; 2007 Jul; 25(6):978-88. PubMed ID: 17499469
[TBL] [Abstract][Full Text] [Related]
18. Robust, unbiased general linear model estimation of phMRI signal amplitude in the presence of variation in the temporal response profile.
Pendse GV; Schwarz AJ; Baumgartner R; Coimbra A; Upadhyay J; Borsook D; Becerra L
J Magn Reson Imaging; 2010 Jun; 31(6):1445-57. PubMed ID: 20512898
[TBL] [Abstract][Full Text] [Related]
19. Imaging of human brain activation with functional MRI.
Moonen CT
Biol Psychiatry; 1995 Feb; 37(3):141-3. PubMed ID: 7727621
[No Abstract] [Full Text] [Related]
20. Atomoxetine produces changes in cortico-basal thalamic loop circuits: assessed by phMRI BOLD contrast.
Easton N; Marshall F; Fone K; Marsden C
Neuropharmacology; 2007 Mar; 52(3):812-26. PubMed ID: 17140608
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
